One of the products with the highest utilization rate in the world is undoubtedly medicines. This rate sometimes causes drugs to be absent from the market and patients to lack the necessary treatment. This is why the industry has been fighting global counterfeiting and black-market activities for many years using serialization. In the recent COVID-19 pandemic, we have all witnessed the scale of these illegal activities. These illegal activities harm public health and cause the loss of prestige of the manufacturing companies.
Last decade, OECD countries have been trying to enact and enforce laws in their countries to combat drug counterfeiting. More than half of these countries enacted laws to ensure pharma traceability and motivated their industries for serialization. Also, legislators of countries outside the union followed these studies and started to combat illegal activities in their countries. Countries will restart accelerating their post-pandemic pharma traceability studies to overcome the supply chain problems during the COVID-19 pandemic.
Therefore, companies will need to comply with the regulations prepared by legislators on pharma traceability in a short time. In this article, we have addressed considered issues to be in the projects to ensure compliance with the regulations.
Please follow our post !!!